ASRS
CLDX icon

Arizona State Retirement System’s Celldex Therapeutics CLDX Stock Holding History

Arizona State Retirement System’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$691K Buy
18,565
+2,139
+13% +$69.1K ﹤0.01% 1384
2026
Q1 		$521K Sell
16,426
-98
-0.6% -$2.67K ﹤0.01% 1436
2025
Q4 		$449K Sell
16,524
-1,125
-6% -$29.6K ﹤0.01% 1543
2025
Q3 		$457K Buy
17,649
+230
+1% +$5.33K ﹤0.01% 1564
2025
Q2 		$354K Buy
17,419
+312
+2% +$6.07K ﹤0.01% 1637
2025
Q1 		$310K Sell
17,107
-195
-1% -$4.36K ﹤0.01% 1660
2024
Q4 		$437K Buy
17,302
+222
+1% +$6.03K ﹤0.01% 1557
2024
Q3 		$581K Buy
17,080
+849
+5% +$32.3K ﹤0.01% 1408
2024
Q2 		$601K Buy
16,231
+325
+2% +$12.3K ﹤0.01% 1322
2024
Q1 		$668K Buy
15,906
+2,148
+16% +$88.2K ﹤0.01% 1275
2023
Q4 		$546K Buy
13,758
+2,322
+20% +$68.3K ﹤0.01% 1394
2023
Q3 		$315K Buy
11,436
+165
+1% +$5.17K ﹤0.01% 1637
2023
Q2 		$382K Buy
11,271
+354
+3% +$11.9K ﹤0.01% 1568
2023
Q1 		$393K Buy
10,917
+359
+3% +$15.5K ﹤0.01% 1546
2022
Q4 		$471K Buy
10,558
+394
+4% +$14.1K ﹤0.01% 1415
2022
Q3 		$286K Buy
10,164
+47
+0.5% +$1.44K ﹤0.01% 1665
2022
Q2 		$273K Buy
10,117
+26
+0.3% +$755 ﹤0.01% 1732
2022
Q1 		$344K Buy
10,091
+83
+0.8% +$2.65K ﹤0.01% 1708
2021
Q4 		$387K Sell
10,008
-542
-5% -$23.6K ﹤0.01% 1688
2021
Q3 		$570K Sell
10,550
-205
-2% -$9.62K ﹤0.01% 1458
2021
Q2 		$360K Sell
10,755
-763
-7% -$20.9K ﹤0.01% 1762
2021
Q1 		$237K Buy
11,518
+171
+2% +$3.93K ﹤0.01% 1943
2020
Q4 		$199K Buy
+11,347
New +$204K ﹤0.01% 1962

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arizona State Retirement System's CLDX Position: Q2 2026 in Review

Arizona State Retirement System increased its Celldex Therapeutics (CLDX) stake by 13% in Q2 2026, buying an estimated $69.1K and bringing the position to 18,565 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Arizona State Retirement System first reported a position in CLDX in Q4 2020 and has held it in 23 quarters since. 254 funds tracked by Wall St. Rank hold CLDX as of Q2 2026.

  • Arizona State Retirement System held 18,565 shares of Celldex Therapeutics worth $691K as of Q2 2026.
  • Arizona State Retirement System bought 2,139 Celldex Therapeutics shares in Q2 2026, an estimated $69.1K.
  • Celldex Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1384 holding.
  • Arizona State Retirement System first reported a position in Celldex Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 254 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.